ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Lazcluze 80 mg, Filmtabletten - 56
69751001 Janssen-Cilag AG
Lazcluze 80 mg, Filmtabletten07.02.2025
  07.02.2025
(L01EB09) 
WHO-DDD06.02.2030
56
07.16.10. 
A  
No 
IPCI
PR  
k.A.PR
  
7680697510018Synthetika
  
Composition
lazertinibum 80 mg ut lazertinibi mesilas monohydricus, silica hydrophobica colloidalis, cellulosum microcristallinum, mannitolum, carmellosum natricum conexum corresp. natrium max. 0.8 mg, magnesii stearas, Überzug: copolymerum macrogolo et alcoholi poly(vinylico) constatum, talcum, E 171, glyceroli monocaprylocapras, E 172 (flavum), poly(alcohol vinylicus), pro compresso obducto.
Packungsbestandteile
Coated tablets
 
Active AgentDose
Lazertinibum80 mg
 
Inactive agents additional_information
(Flavum)  
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
Copolymerum Macrogolo et Alcoholi Poly(Vinylico) Constatum Überzug
E 171 color.
E 172 color.
Glyceroli Monocaprylocapras  
Magnesii Stearas  
Mannitol  
Poly(Alcohol Vinylicus)  
Pro Compresso Obducto  
Silica Hydrophobica Colloidalis  
Talcum  
Source
Data was imported : 12.03.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home